Clinical Trial Update: Nesiritide in Chronic Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update for Nesiritide in chronic heart failure; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: University of Chicago | Conditions: Heart Failure | Phase 2 | Status: TERMINATED